Latest News
Xencor, Inc.
- Xencor, Inc. Estimates – MUN:XE9
- Xencor, Inc. (XNCR) - What Are Researchers Saying About This Stock?
- Xencor (XNCR) Following XmAb819 Webcast Plans, Is The Pipeline Narrative Starting To Look Undervalued?
- Learn Why The Bull Case For Xencor Stock Could Change Following Phase 1 Cancer Results
- Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
- Xencor to present phase 1 data for kidney cancer treatment By Investing.com
- Truist raises target for Xencor stock to USD 29
- Xencor Stock: Better Funding For Obexelimab (NASDAQ:XNCR)
- Xencor's $105M settlement boosts its runway to FDA decision on obexelimab for IgG4-related disease.
- Wells Fargo & Company Initiates Coverage on Xencor (NASDAQ:XNCR)
- Xencor (XNCR) Faces A Fresh Valuation Test As Antibody Platform Hopes Build
- Xencor, Inc. $XNCR Shares Newly Bought by Bank of America Corp DE
Headlines from the last 30 days, linking to the original publishers. See all market news →